Who Cannot Take Nattokinase? Contraindications, Risks & Safety

Nattokinase is a fibrinolytic enzyme that dissolves blood clots and reduces fibrin accumulation, which makes it valuable for cardiovascular health — but also genuinely risky for certain individuals. People taking blood-thinning medications, those with bleeding disorders, or anyone scheduled for surgery are among the groups who should avoid it without medical supervision.

How Nattokinase Works and Why It Carries Risk

Nattokinase is a serine protease enzyme extracted from natto, a fermented soybean food. It works by directly breaking down fibrin — the protein scaffold of blood clots — and by activating the body's own plasminogen system. This fibrinolytic (clot-dissolving) activity is the source of both its cardiovascular benefit and its primary risks. Because it actively reduces clot formation, any condition or medication that already affects bleeding or coagulation creates a compounding hazard.

Key Groups Who Should Avoid Nattokinase

1. People on anticoagulant or antiplatelet medications

This is the most clinically significant contraindication. Combining nattokinase with drugs such as warfarin, heparin, rivaroxaban, apixaban, clopidogrel, or aspirin significantly amplifies bleeding risk. The enzyme's fibrinolytic action stacks on top of the drug's mechanism, increasing the likelihood of excessive or uncontrolled bleeding, including dangerous internal hemorrhage.

2. Individuals with bleeding disorders

People with haemophilia, von Willebrand disease, thrombocytopenia, or any other condition that impairs normal clotting should not use nattokinase. Their baseline clotting capacity is already reduced, and a fibrinolytic enzyme may push the balance further toward uncontrolled bleeding.

3. Pre- and post-surgical patients

Nattokinase should be discontinued at least two weeks before any planned surgery or invasive dental procedure. Surgeons need normal clotting function to control intraoperative bleeding. Post-operatively, the healing process also depends on intact fibrin scaffolding, and premature clot dissolution can reopen wounds or impair tissue repair.

4. Pregnant and breastfeeding individuals

There is insufficient human clinical data on nattokinase safety during pregnancy or lactation. Given the enzyme's potent activity on the coagulation system — which is critically altered during pregnancy — this population should avoid it unless explicitly directed by a qualified healthcare provider.

5. People with recent stroke history (especially haemorrhagic stroke)

While nattokinase has been studied for ischaemic stroke prevention, it is contraindicated in haemorrhagic stroke, where bleeding in the brain is the underlying problem. Using a fibrinolytic agent in this context could worsen the bleed or hinder recovery.

6. Those with peptic ulcers or active internal bleeding

Any condition involving active mucosal or internal bleeding is a contraindication. Nattokinase may inhibit the local clotting response needed to seal damaged tissue.

What About Soy Allergy?

Nattokinase from natto is derived from fermented soybeans. Individuals with soy allergies should exercise caution, particularly with whole-food-derived preparations. The enzyme itself is a protein distinct from common soy allergens, and highly purified nattokinase supplements often contain minimal soy protein — but the risk is not zero. Always check the product specification and consult an allergist if in doubt.

Drug Interactions Beyond Anticoagulants

Beyond blood thinners, nattokinase may interact with:

• NSAIDs (ibuprofen, naproxen): both impair platelet function, increasing combined bleeding risk.
• Vitamin E and fish oil at high doses: additive antiplatelet effects.
• Herbal supplements with blood-thinning properties (e.g., ginkgo, garlic, turmeric extracts): combined use warrants caution.

Always disclose supplement use to a prescribing clinician, as nattokinase does not always appear on standard medication reconciliation forms.

Practical Guidance for Those Who Can Use It Safely

For healthy adults without the above contraindications, nattokinase is generally well tolerated in doses ranging from 100–200 mg (approximately 2,000–4,000 fibrinolytic units) per day. It is typically taken on an empty stomach to optimise absorption. Start at the lower end of the dosage range and monitor for any unusual bruising, prolonged bleeding from cuts, or blood in urine or stool — all of which warrant immediate discontinuation and medical review.

---

Related Topics

• Heart Health Supplements
• Inflammation & Systemic Support
• Longevity & Healthy Ageing